Autologous stem cell transplantation is part of the standard treatment paradigm for a number of blood cancers, including multiple myeloma. In autologous stem cell transplantation, the patient's own stem cells are collected from their blood or bone marrow prior to receiving high-dose chemotherapy, then infused back into the patient, where they travel back to the bone marrow to begin producing new blood cells.

Drugs used to treat Hematopoietic Stem Cell Mobilization